Compound 76
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(C(=O)Nc3ccc(CCO)cc3)c(F)c2)c1=O
- InChi:
InChI=1S/C30H22F4N6O3/c1-39-27-22(15-35-39)26-24(25(37-27)17-3-2-4-18(13-17)30(32,33)34)29(43)40(38-26)20-9-10-21(23(31)14-20)28(42)36-19-7-5-16(6-8-19)11-12-41/h2-10,13-15,38,41H,11-12H2,1H3,(H,36,42)
- InChiKey:
ZOZXUGMEIQJOIS-UHFFFAOYSA-N
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 7.19 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 590.17 g/mol | |||
HBA | 9 | |||
HBD | 3 | |||
HBA + HBD | 12 | |||
AlogP | 5.75 | |||
TPSA | 112.38 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5136 | Riociguat | DB08931 | |
0.5000 | Merestinib | DB12381 | |
0.4981 | Vericiguat | DB15456 | |
0.4904 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4779 | ATX-914 | DB12673 | |
0.4682 | Ravoxertinib | DB15281 | |
0.4667 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4660 | Risdiplam | DB15305 | |
0.4558 | AMG-510 | DB15569 | |
0.4552 | Dilmapimod | DB12140 | |
0.4521 | Lorecivivint | DB14883 | |
0.4448 | TAS-116 | DB14876 | |
0.4440 | E-6005 | DB12776 | |
0.4423 | Abemaciclib | DB12001 | |
0.4384 | MK-1775 | DB11740 |